53
Views
0
CrossRef citations to date
0
Altmetric
Original Research

The effects of prior calcium channel blocker therapy on creatine kinase-MB levels after percutaneous coronary interventions

, , , , , , & show all
Pages 1417-1422 | Published online: 05 Dec 2008

References

  • AbdelmeguidAETopolEJWhitlowPL1996Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventionsCirculation941528368840840
  • AbdelmeguidAETopolEJ1996The myth of the myocardial ‘infarctlet’ during percutaneous coronary revascularization proceduresCirculation943369758989153
  • AkkerhuisKMAlexanderJHTardiffBE2002Minor myocardial damage and prognosisCirculation105554611827918
  • AronowHDMcRaeTQuinnMJ2002bPatients on lipid-lowering therapy at the time of myocardial infarction have smaller infarcts: further evidence to suggest a salutary effect in acute coronary syndrome [abstract]J Am Coll Cardiol39318A
  • AronowHDQuinnMJGurmHS2002aMyocardial necrosis is halved in patients undergoing elective percutaneous coronary intervention who are pretreated with lipid-lowering therapy [abstract]J Am Coll Cardiol3932A
  • BestehornHPNeumannFJBüttnerHJ2004Evaluation of the oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention. The randomized, double-blind, placebo-controlled, multicenter verapamil slow-release for prevention of cardiovascular events after angioplasty (VESPA) trialJ Am Coll Cardiol432160515193674
  • CaliffRMAbdelmeguidAEKuntzRE1998Myonecrosis after revascularization proceduresJ Am Coll Cardiol31241519462562
  • DemirIYilmazHErmis¸C2002Treatment of no reflow phenomenon with verapamil after primary stent deployment during myocardial infarctionJpn Heart J435738012558122
  • DensJDesmetWPiessensJ2003An updated meta-analysis of calcium-channel blockers in the prevention of restenosis after coronary angioplastyAm Heart J145404812660661
  • DesmetWJDensJCoussementP2002Does adenosine prevent myocardial micronecrosis following percutaneous coronary intervention? The ADELINE pilot trial. ADEnosine Limit myocardial NecrosisHeart88293512181228
  • EllisSSorinJBLincoffAM2001Beta-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme riseCirculation1042685811723019
  • [ENCORE] The ENCORE Investigators2003Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin in Recovery of coronary Endothelial function)Circulation107422812551866
  • [EPISTENT] The EPISTENT Investigators1998Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockadeLancet35287929672272
  • FoltsJD1997Inhibition of platelet activity in vivo by amlodipine alone and combined with aspirinInt J Cardiol62S11179488202
  • HerrmannJLermanABaumgartD2002Preprocedural statin medication reduces the extent of per procedural non-Q-wave myocardial infarctionCirculation1062180312390944
  • KleinHHPichSLindertS1989Comparative study on the enchanment of ischemic tolerance by intracoronary pretreatment with three calcium antagonists in pig heartsCardiovasc Drugs Ther2815212488097
  • KurzDJNaegeliBBertelO2000A double-blind, randomized study of the effect of immediate intravenous nitroglycerin on the incidence of postprocedural chest pain and minor myocardial necrosis after elective coronary stentingAm Heart J139354310618560
  • MatthewsMAKunselmanSJGaschoJA2005Differential release of cardiac enzymes after percutaneous coronary interventionCatheter Cardiovasc Interv65192415812827
  • MichaelsADApplebyMOttenMH2002Pretreatment with intra-graft verapamil prior to PCI of saphenous vein graft lesions: results of the randomised controlled vasodilator prevention on no-reflow (VAPOR) trialJ Invasive Cardiol1429930212042618
  • PasceriVPattiGNuscaAARMYDA Investigators2004Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) studyCirculation110674815277322
  • RobertsRRogersWJMuellerHS1991Immediate versus deferred B-blockage following thrombolytic therapy in patients with acute myocardial infarction: results of the thrombolysis in myocardial infarction (TIMI) II-B studyCirculation83422371671346
  • SatoMHardingSEPoole-WilsonPA2004B-blockers, myocardial ischemia and collateral circulationEur Heart J25537915120048
  • SharmaSKKiniAMarmurJD2000Cardioprotective effect of prior B-blocker therapy in reducing creatine- kinase-MB elevation after coronary intervention: benefit is extended to improvement in intermediate-term survivalCirculation1021667210889126
  • SimoonsMLvan den BrandMLincoffM1999Minimal myocardial damage during coronary intervention is associated with impaired outcomeEur Heart J201112910413641
  • TaddeiSVirdisAGhiadoniL2001Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertensionHypertension37943811244022
  • TardiffBECaliffRMTchengJE1999Clinical outcomes after detection of elevated cardiac enyzmes in patients undergoing percutaneous intervention. IMPACT II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-IIJ Am Coll Cardiol3388969935014
  • VoisardRKoschnickSBaurR1997High-dose diltiazem prevents migration and proliferation of vascular smooth muscle cells in various in-vitro models of human coronary restenosisCoron Artery Dis81892019237030
  • WangFWOsmanAOteroJ2003Distal myocardial protection during percutaneous coronary intervention with an intracoronary beta-blockerCirculation1072914912771007
  • WernerGSLangKKuehnertH2002Intracoronary verapamil for reversal of no-reflow during coronary angioplasty for acute myocardial infarctionCathet Cardiovasc Interv5744451
  • YangZNollGLuscherTF1993Calcium channel antagonists differently inhibit proliferation of human coronary smooth muscle cells in response to pulsatile stretch and platelet derived growth factorCirculation8883268353912